Regulatory

After denying petitions to allow NAC's marketing as a dietary supplement, the Food and Drug Administration is moving forward with a draft guidance.

FDA denied requests to reverse its stance that a popular ingredient is excluded from the definition of a dietary supplement, but there are silver linings.

Formation of the International Sustainability Standards Board indicates it's time to apply uniform, universal standards to ESG reporting.

Mineral gets grudging support for one health concern out of hundreds of body functions.

The FDA has rejected NDI submissions from Charlotte's Web and Irwin Naturals and the agency's objections suggest regulators have little interest in approving CBD without legislative guidance.

Will a nutrient content claim crackdown ensue?

The USDA has extended the public comment period for its proposed regulation of certain genetically engineered animals until May 7.